← FDA DRUG APPROVALS

FDA ANDA · ANDA078368

FOMEPIZOLE

Sponsor: AM REGENT

APPLICATION
ANDA078368
TYPE
ANDA
ORIGINAL APPROVAL
2007-12-14
LATEST ACTION
2020-12-23
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FOMEPIZOLEPrescription
FOMEPIZOLE 1.5GM/1.5ML (1GM/ML) · INJECTABLE · INJECTION

Approval history

2020-12-23Labeling · Supplement 9 · standardAP
2007-12-14OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →